Immunogenicity, Lot Consistency, and Extended Safety of rVSVΔG-ZEBOV-GP Vaccine: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study in Healthy Adults
Author:
Affiliation:
1. Canadian Center for Vaccinology, Dalhousie University, IWK Health Centre, and Nova Scotia Health Authority, Halifax, Canada
2. Merck & Co., Inc., Kenilworth, New Jersey
3. NewLink Genetics, Inc., BioProtection Systems, Ames, Iowa
Abstract
Funder
Merck Sharp & Dohme Corp.
Department of Health and Human Services
Publisher
Oxford University Press (OUP)
Subject
Infectious Diseases,Immunology and Allergy
Link
http://academic.oup.com/jid/advance-article-pdf/doi/10.1093/infdis/jiz241/28953870/jiz241.pdf
Reference30 articles.
1. Ebola haemorrhagic fever;Feldmann;Lancet,2011
2. After Ebola in West Africa—unpredictable risks, preventable epidemics;WHO Ebola Response Team;N Engl J Med,2016
3. Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses.;Garbutt;J Virol,2004
Cited by 40 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Translational success of fundamental virology: a VSV-vectored Ebola vaccine;Journal of Virology;2024-02-02
2. Immunogenicity and safety of ebolavirus vaccines in healthy adults: a systematic review and meta-analysis of randomized controlled trials;Expert Review of Vaccines;2023-12-22
3. Immunogenicity and Vaccine Shedding After 1 or 2 Doses of rVSVΔG-ZEBOV-GP Ebola Vaccine (ERVEBO®): Results From a Phase 2, Randomized, Placebo-controlled Trial in Children and Adults;Clinical Infectious Diseases;2023-11-15
4. Emerging Infectious Diseases Are Virulent Viruses—Are We Prepared? An Overview;Microorganisms;2023-10-24
5. Developing Vaccines to Improve Preparedness for Filovirus Outbreaks: The Perspective of the USA Biomedical Advanced Research and Development Authority (BARDA);Vaccines;2023-06-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3